Tag: allergy

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy^® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions

Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of...

The evolving peanut allergy treatment market landscape features clinical trials led by DBV Technologies (Viaskin Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abello (Sublingual...

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys...

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /CNW/ -- BioVaxys...

Icy Hot® & The Shaquille O’Neal Foundation Launch Latest Comebaq Court, in Partnership with Boys & Girls Club of Northeast Texas

ROCKWALL, Texas, July 15, 2025 /PRNewswire/ -- On July 14th, Icy Hot, an Opella Brand, and The Shaquille O'Neal Foundation announced the opening of their...

Grounding Wellness Named #1 Best Grounding Sheet by Union Jack News

Grounding sheet technology promotes restful sleep and wellness

Coway Brings Premium Air Purification Into More Australians’ Homes with the Compact Airmega 50

Coway is expanding its Airmega lineup with its smallest and most affordable model to dateQuiet yet powerful, the Airmega 50 is designed for personal...

GROWNSY Achieves Milestone on Prime Day, Empowering Modern Parenting with Innovation and Trust

NEW YORK, July 14, 2025 /PRNewswire/ -- GROWNSY, a modern innovator in baby care solutions, reached a significant milestone during this year's Prime Day....

FSA Store® shares three things consumers should do now to avoid forfeiting FSA (flexible spending account) funds in December

Consumers collectively forfeit over $3 billion each year in unused FSA funds to the December 31 use-it-or-lose-it deadline, but FSA education and guaranteed-eligible shopping...

Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information

ARLINGTON, Va., July 10, 2025 /PRNewswire/ -- Kalorama Information, a leading healthcare market intelligence firm, has published a comprehensive new report, Global Immunoassay Market:...

Gozellix Receives Permanent HCPCS Code

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA¹ PET² imaging agent, Gozellix® (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection), has been granted a permanent Healthcare Common Procedure Coding System (HCPCS) code by the U.S. Centers for Medicare & Medicaid Services (CMS).

Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and XGEVA® (denosumab) respectively,STOBOCLO and OSENVELT, among the first...

Sun’s Out, Fun’s On Deck: 8 Ways to Use Tax-free Flexible Spending Account (FSA), Health Savings Account (HSA) Funds to Protect Your Health this...

From award-winning skincare products to first aid, hydration, sunscreen, and bug bite relief, FSAs and HSAs help families and individuals make the most of summer fun...

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients...

-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population --

-- Bezuclastinib demonstrated a powerful effect on mast cell burden, with 87.4% of patients treated with bezuclastinib achieving at least 50% reduction in serum tryptase compared to 0% of patients treated with placebo --

Éduc’alcool welcomes Yvan Gendron as Chair of its Board of Directors

Topic: Binance Commits $250,000 to Support Frontline Ebola Response in Uganda and DRC

CORRECTION — Mysti’s Adult and Family Services Begins Statewide Rental Assistance Program Under Washington’s Health-Related Social Needs Initiative

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of...

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

Icy Hot® & The Shaquille O’Neal Foundation Launch Latest Comebaq Court, in Partnership with Boys & Girls Club of Northeast Texas

Grounding Wellness Named #1 Best Grounding Sheet by Union Jack News

Coway Brings Premium Air Purification Into More Australians’ Homes with the Compact Airmega 50

GROWNSY Achieves Milestone on Prime Day, Empowering Modern Parenting with Innovation and Trust

FSA Store® shares three things consumers should do now to avoid forfeiting FSA (flexible spending account) funds in December

Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information

Gozellix Receives Permanent HCPCS Code

Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)

Sun’s Out, Fun’s On Deck: 8 Ways to Use Tax-free Flexible Spending Account (FSA), Health Savings Account (HSA) Funds to Protect Your Health this...

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients...

Explore

Press Releases

News & Opinion

Living

Others

Follow us